Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Clinical Characteristics, Course, and Recommendations for Diagnostic Criteria

Archives of Neurology

Volumn 46, Issue 8, 1989, Pages 878-884

  Barohn, Richard J ^a   Kissel, John T ^a   Warmolts, John R ^a   Mendell, Jerry R ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

ADULT; DEMYELINATION; ELECTROMYOGRAPHY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NERVE BIOPSY; PRIORITY JOURNAL;

BIOPSY; DEMYELINATING DISEASES; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMAN; IMMUNOSUPPRESSION; INFLAMMATION; MALE; MOTOR NEURONS; NEURAL CONDUCTION; NEUROLOGIC EXAMINATION; POLYRADICULONEUROPATHY; PROGNOSIS; SURAL NERVE;

EID: 0024308913     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1989.00520440064022     Document Type: Article

References (33)

1. Austin JH. Recurrent polyneuropathies and their corticosteroid treatment. Brain. 1958;81:157-192.
2. Thomas PK, Lascelles RG, Hallpike JF, Hewer RL. Recurrent and chronic relapsing Guillain-Barre polyneuritis. Brain. 1969;92:589-606.
3. Matthews WB, Howell DA, Hughes RD. Relapsing corticosteroid-dependent polyneuritis. J Neurol Neurosurg Psychiatry. 1970;33:330-337.
4. DeVivo DC, Engel WK. Remarkable recovery of a steroid-responsive recurrent polyneuropathy. J Neurol Neurosurg Psychiatry. 1970;33:62-69.
5. Dolman CL, Allen BM. Relapsing hypertrophic neuritis. Arch Neurol. 1973;28:351-353.
6. Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV. Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc. 1975;50:621-637.
7. Prineas JW, McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci. 1976;27:427-458.
8. Oh SJ. Subacute demyelinating polyneuropathy responding to corticosteroid treatment. Arch Neurol. 1978;35:509-516.
9. Server AC, Lefkowith J, Braine H, McKhan GM. Treatment of chronic relapsing inflammatory polyradiculoneuropathy by plasma exchange. Ann Neurol. 1979;6:258-261.
10. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol. 1981;9:134-145.
11. Pollard JD, McLeod JG, Gatenby P, Kronenberg H. Prediction of response to plasma exchange in chronic relapsing polyneuropathy. J Neurol Sci. 1983;58:269-287.
12. Dyck PJ, O'Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol. 1982;11:136-141.
13. Dyck PJ, Arnason B. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Phildelphia, Pa: WB Saunders Co; 1984;2101-2114.
14. Dyck PJ, Daube J, O'Brien P, et al. Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med. 1986;314:461-465.
15. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain. 1987;110:1617-1630.
16. Lewis RA, Sumner AJ. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology. 1982;32:592-596.
17. Cornblath DR, Drachman DB, Griffin JW. Demyelinating motor neuropathy in patients with diabetic polyneuropathy. Ann Neurol. 1987;22:126. Abstract.
18. Thomas PK, Walker RWH, Rudge P, et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain. 1987;110:53-76.
19. Mendell JR, Kolkin S, Kissel JT, Weiss KL, Chakeres DW, Rammohan K. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 1987;37:1291-1294.
20. Rubin M, Karpati G, Carpenter S. Combined central and peripheral myelinopathy. Neurology. 1987;37:1287-1290.
21. Asbury AK, Arnason BG, Karp HR, McFarlin DE. Criteria for diagnosis of Guillain-Barre syndrome. Ann Neurol. 1978;3:565-566.
22. Mendell JR, Sahenk Z, Whitaker JN, et al. Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Ann Neurol. 1985;17:243-254.
23. Mendell JR, Kissel JT, Kennedy MS, et al. Plasma exchange and prednisone in Guillain-Barre syndrome: a controlled randomized trial. Neurology. 1985;35:1551-1555.
24. Brooke MH, Fenichel GM, Griggs RC, et al. Clinical investigation in Duchenne dystrophy, II: determination of the 'power' of therapeutic trials based on the natural history. Muscle Nerve. 1983;6:91-103.
25. Warmolts JR, Mendell JR, O'Dorisio TM, Cataland S. Comparison of the effects of continuous subcutaneous infusion and split-mixed injection of insulin or nerve function in type 1 diabetes mellitus. J Neurol Sci. 1987;82:161-169.
26. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1985;8:528-539.
27. Kelly JJ. The electrodiagnostic findings in the peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve. 1983;6:504-509.
28. Ramirez JA, Mendell JR, Warmolts JR, Griggs RC. Phenytoin neuropathy: structural changes in the sural nerve. Ann Neurol. 1986;19:162-167.
29. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol. 1981;10:222-226.
30. Cornblath DR, McArthur JC, Kennedy PGE. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987;21:32-40.
31. McKhann GM, Griffin JM, Cornblath DR, et al. Plasmapheresis and Guillain-Barre syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol. 1988;23:347-353.
32. Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barre syndrome: description and prognostic value. Ann Neurol. 1988;23:354-359.
33. Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin Proc. 1982;57:239-246.